CKPT
$1.30
Checkpoint Therapeutics
$.04
3.17%
CKPT
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.17)
Revenue:  N/A
Thursday
Aug 25
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CKPT reports earnings?
Beat
Meet
Miss

Where is CKPT's stock price going from here?
Up
Flat
Down
Stock chart of CKPT
Analysts
Summary of analysts' recommendations for CKPT
Score
Grade
Pivots
Resistance
$1.41
$1.36
$1.33

$1.28

Support
$1.25
$1.20
$1.17
Tweet
Growth
Description
Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.